Generation Bio Co. lost $1.98 per diluted share in fiscal year 2024. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 6 fiscal years, from 2019 to 2024, and the quarters Generation Bio Co. has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Generation Bio Co. lost $1.98 per diluted share in fiscal year 2024.
Generation Bio Co. (GBIO) reported a loss of $1.96 per diluted share in fiscal year 2023 and a loss of $1.98 per diluted share in fiscal year 2024. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Across the 6 fiscal years this page covers, Generation Bio Co. (GBIO) diluted earnings per share went from -$12.96 in fiscal year 2019 to -$1.98 in fiscal year 2024.
Generation Bio Co. (GBIO) reported -$0.82 in diluted earnings per share in Q3 2025.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Generation Bio Co. (GBIO) reported on that line in every period on record.
